)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Stryker (SYK) investor relations material
Stryker Investor Day 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor Day 2025 summary13 Nov, 2025
Strategic direction, business model evolution, and growth priorities
Updated strategy emphasizes digital solutions, operational excellence, and a shift to embedding lean and margin expansion into company culture.
Decentralized business unit model expanded to 22 units, fostering specialization, autonomy, and accountability, with new units like SmartCare for healthcare IT.
Focus on market-leading growth and category leadership in MedSurg, Neurotechnology, and Orthopaedics, with specialized business units driving customer engagement and innovation.
Continued prioritization of M&A, with over 60 acquisitions in the past 10 years and a robust pipeline for future deals, especially in fast-growing adjacencies like healthcare IT and peripheral vascular.
Commitment to responsible and sustainable practices, talent development, and a mission-driven, inclusive culture, with increased cross-business cooperation.
Innovation, product development, and operational excellence
Power brands like Mako, Triathlon, and Inari drive growth through continuous innovation, with new launches such as Mako 4 and upcoming Mako RPS for handheld robotics.
Expansion into new clinical areas (e.g., spine, shoulder, revision hip) and integration of AI and digital tools to enhance product value and customer experience.
SmartHospital Platform introduced as a unified, cloud-native digital foundation to connect clinical systems, devices, and workflows, enhancing care and operational efficiency.
Recent acquisitions, including Inari, care.ai, and Vertos, expand capabilities in vascular, digital, and interventional solutions, positioning the company as a leader in peripheral vascular.
Operational excellence, lean initiatives, and digital transformation drive best-ever cost reductions, inventory optimization, and enterprise productivity.
Financial guidance, performance, and outlook
Achieved organic sales CAGR of 10% since 2020, with 2025 estimated net sales of $25B and adjusted operating margin returning to pre-COVID levels at 26.3%.
Operating margin expansion target increased to 150+ basis points over 2026–2028, including M&A dilution.
Double-digit adjusted EPS growth and 70–80% free cash flow conversion expected to continue annually.
Capital allocation remains heavily weighted to M&A (over 69%), with dividend growth moderating and minimal share buybacks.
International growth remains a focus, with delayed product launches in Europe due to regulatory hurdles but strong prospects in other regions.
Next M&A adjacencies beyond HCIT/vascular?
Key drivers for 150bps margin expansion
Smart Hospital platform's new revenue streams?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Stryker earnings date
Q4 202530 Jan, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
A Pioneer in Medical Technologies
Stryker Corporation is an American medical technology company listed on the NYSE. Headquartered in Kalamazoo, Michigan, the company's operations extend across the globe, serving customers in over 100 countries. Stryker was founded in 1941 by Dr. Homer Stryker, an orthopedic surgeon from Michigan, the company has anchored its reputation on its range of medical devices. Stryker's products encompass a vast segment with everything from orthopedic implants to surgical instruments, and even hospital beds.
Building Upon Dr. Stryker’s Legacy
Dr. Homer Stryker's initial inventions, such as the mobile hospital bed and the turning frame, set the stage for the company's trajectory. Over the years, Stryker Corporation expanded its portfolio, venturing into various medical specialties, such as neurotechnology, spinal surgery, and endoscopy. Strategic acquisitions have played a crucial role in Stryker's growth and the company has absorbed various businesses within the industry, diversifying and expanding its portfolio. When looking at publicly traded peers to Stryker we find names like Medtronic and Abbott Laboratories as well as numerous divisions of massive international corporations such as GE.
Three Focus Areas
Stryker's products can be broadly categorized into three major sectors: Orthopedics, MedSurg, and Neurotechnology & Spine.
The Orthopedics division focuses on joint replacements, trauma and extremities, and other orthopedic surgeries. Products like hip and knee joint replacements and bone cement fall under this bracket.
MedSurg encompasses a wider spectrum. This category includes surgical equipment, navigation systems, patient-handling solutions, and emergency medical equipment. Noteworthy mentions include the power tools for precise bone surgeries and the 1588 AIM camera system for endoscopic surgeries.
The Neurotechnology & Spine department designs and manufactures equipment for the intricacies of neuro and spine surgeries. This division offers products like the Neuroform Atlas Stent System for brain aneurysm treatment and the LITe Decompression System for spine surgeries.
Dedicated Research and Development
Behind Stryker's extensive product portfolio lies its steadfast commitment to research and development. The company continually invests in R&D, ensuring its products not only meet but often exceed industry standards. This commitment to innovation is evident in the company's historically consistent rollout of advanced medical devices, many of which have been firsts in their respective fields.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage